Skip to Main Content

Paper Details

CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity.
J Immunother Cancer
1
2023
Author NameAffiliation
Kostyantyn KrysanDavid Geffen School of Medicine at university of california los angeles
Aaron LisbergDavid Geffen School of Medicine at university of california los angeles
Aaron LisbergDavid Geffen School of Medicine at university of california los angeles
Edward B GaronDavid Geffen School of Medicine at university of california los angeles
Edward B GaronDavid Geffen School of Medicine at university of california los angeles
Steven M DubinettDavid Geffen School of Medicine at university of california los angeles
Steven M DubinettVA Greater Los Angeles Healthcare System
Steven M DubinettDavid Geffen School of Medicine at university of california los angeles
Steven M DubinettVA Greater Los Angeles Healthcare System
  • 1 - 9

Datasets

Release 1.2